Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others; and End User: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Direct-to-Consumer Laboratory Testing Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2030

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

    5.2. Disease Prevalence & Incidence Rate

    5.3. Regulatory Scenario

    5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2030

        6.3.1. Genetic testing

        6.3.2. Disease risk assessment testing

            6.3.2.1. Cancer

            6.3.2.2. STDs

            6.3.2.3. Others

        6.3.3. CBC

        6.3.4. Diabetes testing

        6.3.5. TSH testing

        6.3.6. Others

    6.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Test Type

7. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type , 2017–2030

        7.3.1. Blood

        7.3.2. Urine

        7.3.3. Saliva

        7.3.4. Others

    7.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Sample Type

8. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2030

        8.3.1. Hospitals

        8.3.2. Clinics

        8.3.3. Specialty labs

        8.3.4. Diagnostic centres

    8.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by End-user

9. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Country/Region

10. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2030

        10.2.1. Genetic testing

        10.2.2. Disease risk assessment testing

            10.2.2.1. Cancer

            10.2.2.2. STDs

            10.2.2.3. Others

        10.2.3. CBC

        10.2.4. Diabetes testing

        10.2.5. TSH testing

        10.2.6. Others

    10.3. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2030

        10.3.1. Blood

        10.3.2. Urine

        10.3.3. Saliva

        10.3.4. Others

    10.4. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2030

        10.4.1. Hospitals

        10.4.2. Clinics

        10.4.3. Specialty labs

        10.4.4. Diagnostic centres

    10.5. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country, 2017–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

        10.6.1. By Test Type 

        10.6.2. By Sample Type 

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2030

        11.2.1. Genetic testing

        11.2.2. Disease risk assessment testing

            11.2.2.1. Cancer

            11.2.2.2. STDs

            11.2.2.3. Others

        11.2.3. CBC

        11.2.4. Diabetes testing

        11.2.5. TSH testing

        11.2.6. Others

    11.3. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2030

        11.3.1. Blood

        11.3.2. Urine

        11.3.3. Saliva

        11.3.4. Others

    11.4. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2030

        11.4.1. Hospitals

        11.4.2. Clinics

        11.4.3. Specialty labs

        11.4.4. Diagnostic centres

    11.5. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

        11.6.1. By Test Type 

        11.6.2. By Sample Type 

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2030

        12.2.1. Genetic testing

        12.2.2. Disease risk assessment testing

            12.2.2.1. Cancer

            12.2.2.2. STDs

            12.2.2.3. Others

        12.2.3. CBC

        12.2.4. Diabetes testing

        12.2.5. TSH testing

        12.2.6. Others

    12.3. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2030

        12.3.1. Blood

        12.3.2. Urine

        12.3.3. Saliva

        12.3.4. Others

    12.4. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2030

        12.4.1. Hospitals

        12.4.2. Clinics

        12.4.3. Specialty labs

        12.4.4. Diagnostic centres

    12.5. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2030

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

        12.6.1. By Test Type 

        12.6.2. By Sample Type 

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2030

        13.2.1. Genetic testing

        13.2.2. Disease risk assessment testing

            13.2.2.1. Cancer

            13.2.2.2. STDs

            13.2.2.3. Others

        13.2.3. CBC

        13.2.4. Diabetes testing

        13.2.5. TSH testing

        13.2.6. Others

    13.3. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2030

        13.3.1. Blood

        13.3.2. Urine

        13.3.3. Saliva

        13.3.4. Others

    13.4. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2030

        13.4.1. Hospitals

        13.4.2. Clinics

        13.4.3. Specialty labs

        13.4.4. Diagnostic centres

    13.5. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Test Type 

        13.6.2. By Sample Type 

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2030

        14.2.1. Genetic testing

        14.2.2. Disease risk assessment testing

            14.2.2.1. Cancer

            14.2.2.2. STDs

            14.2.2.3. Others

        14.2.3. CBC

        14.2.4. Diabetes testing

        14.2.5. TSH testing

        14.2.6. Others

    14.3. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2030

        14.3.1. Blood

        14.3.2. Urine

        14.3.3. Saliva

        14.3.4. Others

    14.4. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2030

        14.4.1. Hospitals

        14.4.2. Clinics

        14.4.3. Specialty labs

        14.4.4. Diagnostic centers

    14.5. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

        14.6.1. By Test Type 

        14.6.2. By Sample Type

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Company Profiles

        15.1.1. Laboratory Corporation of America Holdings

            15.1.1.1. Company Overview

            15.1.1.2. Company Financials

            15.1.1.3. Growth Strategies

            15.1.1.4. SWOT Analysis

        15.1.2. Quest Diagnostics Incorporated

            15.1.2.1. Company Overview

            15.1.2.2. Company Financials

            15.1.2.3. Growth Strategies

            15.1.2.4. SWOT Analysis

        15.1.3. 23andMe, Inc.

            15.1.3.1. Company Overview

            15.1.3.2. Company Financials

            15.1.3.3. Growth Strategies

            15.1.3.4. SWOT Analysis

        15.1.4. EverlyWell, Inc

            15.1.4.1. Company Overview

            15.1.4.2. Company Financials

            15.1.4.3. Growth Strategies

            15.1.4.4. SWOT Analysis

        15.1.5. DirectLabs, LLC

            15.1.5.1. Company Overview

            15.1.5.2. Company Financials

            15.1.5.3. Growth Strategies

            15.1.5.4. SWOT Analysis

        15.1.6. Ancestry

            15.1.6.1. Company Overview

            15.1.6.2. Company Financials

            15.1.6.3. Growth Strategies

            15.1.6.4. SWOT Analysis

        15.1.7. MyMedLab, Inc.

            15.1.7.1. Company Overview

            15.1.7.2. Company Financials

            15.1.7.3. Growth Strategies

            15.1.7.4. SWOT Analysis

        15.1.8. WellnessFX

            15.1.8.1. Company Overview

            15.1.8.2. Company Financials

            15.1.8.3. Growth Strategies

            15.1.8.4. SWOT Analysis

        15.1.9. ANY LAB TEST NOW

            15.1.9.1. Company Overview

            15.1.9.2. Company Financials

            15.1.9.3. Growth Strategies

            15.1.9.4. SWOT Analysis

        15.1.10. LetsGetChecked

            15.1.10.1. Company Overview

            15.1.10.2. Company Financials

            15.1.10.3. Growth Strategies

            15.1.10.4. SWOT Analysis

        15.1.11. Color Genomics

            15.1.11.1. Company Overview

            15.1.11.2. Company Financials

            15.1.11.3. Growth Strategies

            15.1.11.4. SWOT Analysis